the Golgi area, cell surface, and nucleus did not exceed background levels (n ϭ 20 cells).
Leucyl-leucyl-norleucinal Inhibits a Protease Involved in Class I Breakdown in US11

؉
Cells and Leads to Accumulation of a 40 kDa Breakdown Intermediate
When cells were exposed to brefeldin A (BFA) to impede trafficking from the ER to the Golgi, no effect on the half life of class I heavy chains was seen in US11 ϩ cells (Figure 3 ). We observe a slight increase ( Figure 3A , com- increase in the concentration of ␤2m is expected to favor (lanes 8-14) . The immunoprecipitates were separated on a 12.5% complex formation. We conclude that transfer from the SDS-polyacrylamide gel and visualized by fluorography.
site of synthesis to a compartment distal to the block The calpain I inhibitor leucyl-leucyl-norleucinal (LLnL) but not the calpain II inhibitor leucyl-leucyl-methional (data not shown) slowed down the disappearance of class I heavy chains in US11 ϩ cells (Figure 3 ). Its applicafor equilibration of intracellular methionine and methiotion resulted in the transient accumulation of an intermenyl tRNA pools at these short pulses, and the time rediate of lower molecular mass (40 kDa). The breakdown quired for completion of the polypeptide chain. From 1 intermediate, to be further characterized below, was to 2 min, over half of the radioactivity in the class I heavy never observed in a complex with ␤ 2 m, and was unreacchains is lost (lanes 2, 3), and beyond 20 min of chase, tive with the W6/32 antibody specific for the assembled no heavy chains remain. This rapid disappearance cancomplex ( Figure 3A , compare lanes 4 and 8 with 12 and not be counteracted by a reduction of temperature: at 16). Application of LLnL to control cells ( Figure 3B ) failed 26ЊC ( Figure 1A , lanes 8-14) or 16ЊC (data not shown), to produce this breakdown intermediate. When unwe observed neither cessation of breakdown, nor the transfected cells were treated with LLnL or BFA, class accumulation of breakdown intermediates. Kinetics of I molecules, both assembled (W6/32 reactive) and free labeling and destruction of heavy chains, not surprisheavy chains, were essentially stable over the 20 min ingly, were slower at the reduced temperatures. We conchase period ( Figure 3B ), during which class I heavy clude that breakdown of class I heavy chains takes place chains are destroyed completely in US11 ϩ cells. There prior to their transport from the ER to the Golgi. Given appeared to be a modest effect of LLnL on the generathe kinetics with which destruction occurs, the process tion of W6/32 reactive assembled complexes (Figure is likely to be initiated immediately upon completion of 3B, compare lanes 2 and 4), possibly owing to inhibitory the polypeptide chain. In cells that do not express US11, effects of LLnL on proteasomal protein breakdown the class I heavy chains are stable over the time course (Rock et al., 1994) . We also observed a slight reduction observed here (Beersma et al., 1993; Jones et al., 1995;  of free heavy chains in BFA-treated cells ( Figure 3B , see also Figure 3B ).
compare lanes 8 and 12), which may be attributable to Class I heavy chain-␤ 2 m complexes can be recovered increased complex formation as a result of a higher by immunoprecipitation with the monoclonal antibody concentration of ␤2m in the ER. W6/32, whereas the rabbit anti-heavy chain serum used here is specific for free class I heavy chains . Both W6/32-reactive and anti-heavy chainThe Light Chain, ␤ 2 m Is Stable and Secreted reactive class I molecules are stable in control U373-in Increased Amounts in US11 ؉ Cells MG cells see below) , whereas both
Owing to the lack of heavy chains with which ␤ 2 m can populations of class I molecule rapidly disappear from pair (Figures 1 and 3 ; see the later time points), the US11 ϩ cells ( Figures 1A and 1B) . The transferrin receptor excess of free ␤ 2m in US11 ϩ cells behaves as a secretory ( Figure 1C ) (Beersma et al., 1993; Jones et al., 1995) protein and can be recovered from the supernate in does not show more rapid decay over the period of increased amounts compared with control cells (Figure observation in US11 ϩ cells than is seen in control cells.
4, compare lanes 2 and 6). Inclusion of the inhibitor LLnL has no effect on the quantity of ␤2m released ( Figure 4 , lanes 2 and 4). Increased survival of class I heavy chains US11 Is an ER-Resident Protein We performed immunoelectron microscopy on ultrathin in the form of the 40 kDa breakdown intermediate induced by LLnL does not promote association with ␤ 2 m cryosections of US11 ϩ cells and their untransfected counterparts. The rabbit anti-US11 antibody gave esand an attendant reduction in the amount of ␤ 2 m secreted. Association of class I heavy chains with ␤ 2 m sentially no labeling on the untransfected cells ( Figure  2A ). In US11 ϩ cells, US11 immunoreactivity was dein the course of biosynthesis is a very rapid process (Heemels and . Therefore the US11 gene tected exclusively in the ER ( Figure 2B ). Labeling over Electron micrographs of ultrathin cryosections from a control cell (A) and a US11 transfected cell (B). The sections were immunogold labeled for US11 with 10 nm gold particles as indicated. In the control cell, two background gold particles can be seen; while in the US11 transfected cell, US11 is present in the ER (26/28 gold particles over the ER). L, lysosome; M, mitochondrion; P, plasma membrane. Bars, 0.2 m.
product renders class I heavy chains less capable of intermediate of the observed mobility, and proteolysis of the COOH-terminal cytoplasmic tail is a rather frequent associating with ␤ 2 m, either by altering the conformation of these heavy chains, or by transferring the heavy chain occurrence for class I molecules. 4; see also Figure 1 ). In US11 ϩ cells exposed to LLnL, Figure 5A shows recovery of class I complexes using we observe the appearance of the 40 kDa intermediate, the W6/32 antibody from control cells exposed to LLnL which persists for 20 min and is completely resistant or BFA. The expected acquisition of partial endo H resisto endo H ( Figure Figure 5A , compare lanes 6 and 8); the reduction 5B, lanes 9-12). We conclude that the breakdown interin total amount of W6/32 reactive complexes may again mediate that transiently accumulates in LLnL-treated be attributable to reduction in peptide pools available US11 ϩ cells contains little if any N-linked glycans. for assembly (Rock et al., 1994) . As expected, treatment with BFA at these relatively early chase points results hydrolyzed, and the Asn sidechain is converted to an ϩ cells, some of the core-glycosylated precursor is observed at the 0 min time point and is still susceptible to N-glycanase digestion. Note that at the 20 min. timepoint, when only the breakdown intermediate is detectable (see Figure  3) , digestion with N-glycanase is without effect on the IEF banding pattern. Moreover, the pattern observed in US11 ϩ cells is indistinguishable from that seen for N-glycanase-digested Class I heavy chains from control cells. The two panels shown are derived from the same electrophoretic separation, but different exposures were required to compensate for levels of incorporation of label. Cathode is at the top.
N-Linked Glycans
Asp residue (reviewed by Tarentino and Plummer, 1994) .
heavy chains with isoelectric points identical to the breakdown intermediates seen in LLnL-treated US11 ϩ Such conversion should result in a change in isoelectric point of the class I heavy chains. cells, and the breakdown intermediates in US11 ϩ cells are refractory to digestion with N-glycanase ( Figure 6C ). When the samples shown in Figure 6A are analyzed by one dimensional isoelectric focusing (IEF), we observe Combined, these data argue strongly in favor of the breakdown intermediate having lost all N-linked oligomultiple bands in the anti-heavy chain precipitates. This multiplicity of bands is due to the simultaneous pressaccharides in an N-glycanase catalyzed reaction, the polypeptide backbone remaining intact. ence of the products of HLA-A, -B, and -C loci, each with a unique isoelectric point (Neefjes et al., 1986) . Most of the class I heavy chains have isoelectric points well
The Absence of N-Linked Glycans Does Not above the pKa of sialic acids or protein-bound phosAffect Breakdown of Class I Heavy Chains phate moieties (Eichholtz et al., 1992) . For each of the in US11 ؉ Cells isoelectric species present at the beginning of the TM treatment of control cells produces the expected chase, the breakdown intermediate seen in LLnLnonglycosylated heavy chains that are stable during the treated cells at later time points migrates at a more 20 min chase ( Figure 7A , compare lanes 1 and 2 with 3 acidic isoelectric point (compare Figures 6A and 6B , and 4). In US11 ϩ cells exposed to TM, breakdown of lanes 1-7 and 8-14). Based on previous observations class I molecules proceeds as it does in untreated US11 et al., 1992) this change in isoelectric point cells ( Figure 7A , compare lanes 5 and 6 with 7 and 8). is of a magnitude comparable to that seen for addition Inclusion of LLnL allows the visualization of the 40 kDa of a single sialic acid residue and thus most likely correintermediate ( Figure 7B , lanes 9-12), and there is no sponds to the conversion of the amide (Asn) to the acid difference in mobility between precursor and breakdown (Asp). 7B, lanes 11 and 12). The increased survival of the breakIn TM-treated cells glycosylation is suppressed, and the down intermediate in TM-treated cells exposed to LLnL acceptor Asn residues persist as such without affecting may be deduced from a comparison of lanes 9 and 10 isoelectric point. The presence of the single remaining with 11 and 12 ( Figure 7B ) and is no less than that GlcNAc residue as produced by digestion with endo H observed when comparing lanes 1 and 2 with 3 and 4 should not affect the isoelectric point of the class I heavy (US11 ϩ cells labeled in the absence of TM). The shift in chains either, and indeed yields digestion products inmobility seen for US11 in TM-treated cells is consistent distinguishable in focusing pattern from class I heavy with the predicted presence of a single N-linked glycan. chains isolated from TM-treated cells (compare lanes Note that US11, in both glycosylated and nonglycosylated form, is stable over the chase period during which 15-17). In vitro treatment of core-glycosylated class I heavy chains with peptide N-glycanase yields class I class I heavy chains are degraded.
was described as a very potent inhibitor of proteasomes (Rock et al., 1994) . We synthesized this compound using solution chemistry and found it to produce a class I breakdown intermediate indistinguishable from that produced in the presence of LLnL ( Figure 7B , compare lanes 3 and 4 with 5 and 6). The antibiotic lactacystin (Fenteany et al., 1995) is perhaps the most specific inhibitor of proteasomes discovered yet: radioactive lactacystin labels only the ␤-type subunit of proteasomes, and the compound is strongly inhibitory on proteasomal proteolysis (Fenteany et al., 1995) . Lactacystin, like LLnL and Cbz-LLL, produces the 40 kDa breakdown intermediate ( Figure 7B , lanes 7 and 8). We conclude that the specificity profile of inhibition indicates the involvement of proteasomes in the destruction of class I heavy chains in US11 ϩ cells.
Subcellular Fractionation Shows Dislocation of the Class I Heavy Chain from the Microsomal Fraction to the Cytosol
Subcellular fractionation experiments were performed on control cells and US11 ϩ cells labeled in the presence of LLnL, as described in the Experimental Procedures. For both control and US11 ϩ cells, the 1000 g pellet 100,000 g supernate ( Figure 8A , Control, lanes 7 and 8), the breakdown intermediate seen in LLnL-treated Because in all likelihood there exist considerable US11 ϩ cells was largely recovered from the 100,000 g pools of preexisting fully glycosylated US11 molecules supernate ( Figure 8A , US11 ϩ , lanes 7 and 8). We therewhen TM treatment and labeling are initiated, we cannot fore conclude that US11 mediates the transfer of the conclude that nonglycosylated US11 is still biologically class I heavy chain from the ER environment to the active; but clearly, nonglycosylated class I molecules cytosolic compartment. In the same subcellular fracare fully susceptible to degradation imposed by the tions, the light chain ␤ 2 m that is not associated with presence of the US11 product.
class I heavy chains (no coprecipitating heavy chains were observed; data not shown) sediments predomiThe Proteasome Inhibitors Carboxybenzyl-Leucylnantly with the microsomal fractions, and its distribution Leucyl-Leucinal and Lactacystin Produce is not noticeably different for control cells and US11 ϩ a Class I Breakdown Intermediate cells ( Figure 8B ). The intracellular compartments that Indistinguishable from that Seen contain ␤ 2 m must therefore remain largely intact in the in LLnL-Treated Cells course of homogenization. This finding also argues Peptide aldehydes such as LLnL have been widely used against breakage of intracellular organelles as the as inhibitors of proteases (Sherwood et al., 1993 ; Rock source of the soluble class I breakdown intermediate in et al., 1994) . Their precise target of inhibition is often US11 ϩ cells, and supports its cytosolic localization. Note difficult to assess, and the rank order of inhibitory pothat recovery of the class I breakdown intermediate ustency on purified proteases derived from different ing anti-heavy chain serum did not require the inclusion sources, such as lysosomal or proteasomal, has been of detergent. used as a criterion for identification of their intracellular
The distribution of US11 itself is indicative of a microtargets (Rock et al., 1994) . For example, whereas LLnL somal localization. Of note, the class I breakdown interhas been described as a calpain I inhibitor, it is known mediate ( Figure 8A , US11 ϩ ) is found in a compartment, to inhibit other proteases, including lysosomal protethe 100,000 g supernate, that is entirely devoid of US11 ases and the proteasome (Rock et al., 1994) . The com-( Figure 8C , US11 ϩ , lanes 7 and 8). Therefore, at the time that the breakdown intermediate has been generated, pound carboxybenzyl-leucyl-leucyl-leucinal (Cbz-LLL) the immune system through down-regulation of MHC class I molecules. In this regard, human cytomegalovirus has been an enigma: in HCMV-infected cells, there is a strong reduction in the cell surface display of host class I molecules, yet the gene(s) responsible, let alone the mechanism(s) by which this is accomplished, have remained obscure until recently.
A systematic search of the HCMV genome revealed the US11 gene as a major determinant of class I instability . With respect to class I heavy chain turnover, cell lines transfected with US11 behave in the same manner as HCMV-infected cells. Pulsechase analysis revealed that all of the class I heavy chains synthesized in a 45 to 60 s pulse were broken down with an initial t1⁄ 2 of <1 min. The occurrence of a core-glycosylated precursor to the breakdown intermediate in US11 ϩ cells shows that initial insertion of Class I heavy chains into the ER takes place normally. Polypeptide chain elongation proceeds at a rate of some 4 amino acids per second (Braakman et al., 1991) , and thus the time required for completion of a 338-residue class I heavy chain (excluding signal peptide) would take ‫08ف‬ s. Destruction of class I molecules in US11 ϩ cells is a process that most likely starts as soon as the polypeptide chain is completed, and must target molecules located in the endoplasmic reticulum, to which US11 itself is confined. No breakdown intermediates could be visualized unless protease inhibitors were included in the labeling and chase medium. An unexpected observation was the identity of a deglycosylated intermediate, the product of an N-glycanase-catalyzed reaction, that transiently accumulated in LLnL-treated US11 ϩ cells. The N-linked glycan itself plays no role in targeting class I heavy chains for destruction.
The specificity of the breakdown process deserves comment. US11 ϩ cells show no apparent growth disadvantage in tissue culture, suggesting that even if multiple substrates were being attacked by this US11-dependent process, no functions essential for growth are compromised. As examples, neither transferrin receptors nor calnexin are affected in their biosynthesis or intracellular ately removing glycans from nascent or newly synthesized glycoproteins, which may depend on these glythere can be no physical interaction between US11 and cans for entering the proper folding or sorting pathway this intermediate. As further controls, we show that nei- (Hammond et al., 1994; Scheiffele et al., 1995) . Is the ther calnexin ( Figure 8D ), nor TfR ( Figure 8E ) are recovpresence of an N-linked glycan on the class I heavy ered from the 100,000 g supernatant.
chain incompatible with its re-entry into the cytosol via the translocation complex by which it entered the ER?
Discussion
The physical dimensions of the pore involved in translocation are not known (Simon and Blobel, 1991) , but at The present study reveals yet another astonishing examleast in bacteria, which possess a homologous translocation complex, nascent chains are accompanied into ple of how virus-infected cells may evade detection by the pore by a second polypeptide, the SecA protein, proteins in the course of translocation. This would be analogous to the function of the mitochondrial matrix which transiently acquires a transmembrane orientation (Economou and Wickner, 1994; Kim et al., 1994) . If two Kar2 homolog, HSP70 (Schneider et al., 1994) . It is at this stage that US11 could interfere with the interactions polypeptide chains can be accomodated simultaneously by the translocation complex, we see no obvious between class I heavy chains and the molecular ratchet. Having failed to properly engage this ratchet, for examimpediment to transport of a glycosylated polypeptide backbone out of the ER.
ple because US11 and the Kar2 equivalent bind to the same key site, the class I molecule may slide back into Second is the ability of a number of protease inhibitors to interfere with the breakdown of class I molecules.
the cytosol after completion of the polypeptide chain. However, Kar2/BiP did not appear to be required for These inhibitors are the peptide aldehydes LLnL and CbzLLL, the latter of which was reported to show strong the cotranslational mode of translocation (Gö rlich et al., 1992; Gö rlich and Rapoport, 1993; Panzner et al., 1995) , preference for inhibition of proteasomal proteolysis, at least in vitro. More convincingly, lactacystin, the only and further experiments will be required to distinguish between the possibilities suggested here. active site-directed inhibitor selective for the proteasomal ␤-type subunits (Fenteany et al., 1995) , also inhibited
Little is known about the pathways in normal cells that lead to destruction of MHC class I molecules, especlass I breakdown and produced the nonglycosylated intermediate. Unless we assume the presence of a hithcially of their intra membrane and cytoplasmic portions. Presumably, the lumenal segments are readily degraded erto undiscovered proteolytic activity in the lumen of the ER that is also a target of inhibition for lactacystin, we when they enter the final part of the endocytic pathway, where the environment is reducing and where the low consider this strong evidence in support of proteasomemediated, and hence a cytosolic location for, US11-pH and abundant proteases finish them off. Indeed, for class I molecules that have exceeded their useful life stimulated breakdown of class I molecules.
Third, the sedimentation behavior of class I molecules span at the cell surface, destruction is preceded by loss of bound peptide and ␤ 2 m (not necessarily in that order) is altered dramatically in cells that express US11. Whereas in normal cells all class I heavy chains as well (Neefjes et al., 1993) , and can be blocked to a significant extent through inactivation of the vacuolar protonas other membrane proteins (TfR, calnexin, and US11 itself) sediment after 1 hr at 100,000 g, most of the 40 pumping ATPase by the macrolide antibiotic concanamycin B (R. Machold and H.L.P., unpublished data). kDa nonglycosylated breakdown intermediates fail to do so under these conditions and are therefore cytosolic
Other type I membrane proteins may follow a similar general scheme for their catabolism. The involvement by definition (Lardy, 1965) .
Current models suggest that, upon arrival of a soof proteasomes in the breakdown of the cystic fibrosis transmembrane conductance regulator (CFTR) protein called stop-transfer signal, type I membrane proteins anchor themselves firmly in the lipid bilayer by lateral was recently suggested, based on the inhibitory effects of Cbz-LLL and lactacystin, as well as the occurrence diffusion out of the protein complex that mediates their cotranslational insertion (Simon and Blobel, 1991) . The of ubiquitinated breakdown intermediates (Jensen et al., 1995; Ward et al., 1995) . It should be noted that the US11 product may allow newly synthesized class I molecules to exit the ER for the cytosol in a reaction that mature form of the CFTR has some 80% of its total mass exposed on the cytosolic face, and that aberrantly represents a reversal of the insertion process, by interference with the reception of this stop-transfer signal.
folded CFTR decays with a t1⁄ 2 of some 30 min. In the case of CFTR, there is no evidence that its membrane Upon termination of the polypeptide chain the ribosome dissociates from the translocation complex. A failure to topology is altered prior to attack by cytosolic proteases. properly exit the translocation complex might allow the polypeptide chain to move in a backward motion toClearly, US11 ϩ transfectants reveal a novel pathway that alters the membrane dispostion and fate of a type wards the cytosol. Access of the newly synthesized class I heavy chain to cytosolic proteases or other pro-I membrane protein. These findings have implications not only for our understanding of the biology of HCMV, teins will likewise require the dissociation of the ribosome. In this model, a specific but transient interaction but also for the biosynthesis and turnover of membrane proteins in general. Viruses have withstood the selective of the lumenal domains of US11 and class I ensures that only class I molecules, and not other membrane or pressures exerted by the host environment through clever exploitation and evasion of cellular mechanisms, secretory proteins, would suffer this fate. Any class I heavy chain that finds itself fully exposed to the cytosolic and have had tens of millions of years to hone these strategies. As far as class I expression is concerned, environment would be broken down rapidly, as are other type I membrane proteins inappropriately expressed in we refer to the recent finding (Frü h et al., 1995; Hill et al., 1995) that HSV comes equipped with a potent inhibitor of the cytosol (Townsend and Bodmer, 1989 ).
An alternative interpretation invokes the involvement the MHC-encoded peptide transporter, the TAP complex, thus thwarting presentation of viral antigen at a of Kar2 or Bip-equivalents. The Kar2 protein in yeast is needed for efficient posttranslational translocation into crucial step in the virus' lifecycle. Every single step in the biogenesis and intracellular transport of class I molethe ER of secretory and membrane proteins in vivo and in vitro (Vogel et al., 1990; Sanders et al., 1992; Panzner cules is a potential target for these stealth strategies.
The present example of US11 shows that this small type et al., 1995) . Its mechanism of action may involve repeated cycles of interaction and disengagement to pro-I membrane glycoprotein may accomplish the elimination of MHC class I products by effectively redirecting duce a "pulling" action via a molecular ratchet, allowing entry and blocking slippage back into the cytosol of the class I heavy chain to the proteolytic machinery of after the chase, samples were placed on ice and lysed in 1 ml of gest mechanisms by which peptides, derived from lumeice-cold NP40 lysis mix. Preparation of lysates and immunoprecipitations were performed as described (Beersma et al., 1993) .
nally disposed proteins, may be generated by the cytosolic protease machinery and delivered to class I
Gel Electrophoresis
molecules by the MHC-encoded peptide transporter.
SDS-PAGE, one-dimensional IEF, and fluorography were performed as described .
Experimental Procedures
Subcellular Fractionation Cells and Cell Culture
Cells (n ϭ 10 8 ) were incubated in methionine-free medium with LLnL U373-MG astrocytoma cells and US11 transfectants prepared from for 1 hr. Cells were then labeled with [ 35 S]methionine (250 Ci/ml) this cell line have been described (Jones et al. 1994 
Antibodies
Cells were homogenized on ice using a Dounce homogenizer (30 For studying assembly of class I molecules, the mouse monoclonal or 50 strokes) with a tight fitting pestle (Thomas, pestle type A). The antibody W6/32, specific for assembled class I molecules, the monohomogenate was spun at 1,000 g for 10 min, which yielded the 1,000 clonal antibody BBM.1 recognizing both free ␤2m and class I heavy g pellet. The supernatant was subjected to 10,000 g centrifugation chain-associated ␤ 2m, and the rabbit anti-class I heavy chain serum for 30 min, which yielded the 10,000 g pellet. Finally, the 10,000 g were used (see Beersma et al., 1993) . The monoclonal antibody supernantant was spun at 100,000 g for 1 hr, which resulted in the 66Ig10 recognizing the human transferrin receptor was used for 100,000 g pellet and the 100,000 g supernatant (cytosol). Lysis mix isolation of TfR, as described (Beersma et al., 1993) . Polyclonal was added to all pellets (but not to the 100,000 g supernatant) and rabbit serum reactive with US11 was described previously (Jones immunoprecipitations, SDS-PAGE, and fluorography were peret al., 1991).
formed as described.
Biochemical Methods and Materials
Immunoelectron Microscopy Leucyl-leucyl-norleucinal (LLnL; Boehringer Mannheim, Germany) U373 cells expressing US11 and control transfected cells were was dissolved in ethanol and used at a final concentration of 50 treated with LLnL as above, or taken directly and processed for M. TM and brefeldin A were from Sigma (Sigma Chemical Co., St.
immunoelectron microscopy as described (Slot et al., 1991; Liou Louis) . Treatment with endoglycosidase H (Endo H; New England and Slot, 1994) using rabbit anti-US11 antiserum and labeled with Biolabs, Beverly) or N-glycanase (Boehringer Mannheim, Germany) 10 nm protein A-gold particles. Sections were contrasted with uranyl were performed as suggested by the manufacturers. Lactacystin and embedded in a mixture of methyl cellulose and uranyl as de-(Fenteany et al., 1995) was used at a final concentration of 20 M.
scribed (Liou and Slot, 1994) . [ 35 S]methionine (1200 Ci/mmol) was from NEN-Du Pont. equivalent of sodium bicarbonate were dissolved in water. Equimolar Cbz-leu-Osu was added as a solution in dioxane and the reaction This work was supported by funding from the National Institutes of Health (H. P. and M. B., grant NIH-5-P30-CA14051). E. J. H. J. W. stirred overnight. Dioxane was removed by rotary evaporation and the dipeptide was precipitated from the remaining water phase by is on leave from the National Institute of Public Health and Environmental Protection (Bilthoven, The Netherlands) and further supaddition of a citric acid buffer. The resulting precipitate was extracted into ethyl acetate and concentrated. Crude dipeptide was ported by a Talent Stipendium of The Netherlands Organization for
